The Chinese Society of Clinical Oncology(CSCO):Clinical guidelines for the diagnosis and treatment of gastric cancer,2021  

作　　者：Feng-Hua Wang Xiao-Tian Zhang Yuan-Fang Li Lei Tang Xiu-Juan Qu Jie-Er Ying Jun Zhang Ling-Yu Sun Rong-Bo Lin Hong Qiu Chang Wang Miao-Zhen Qiu Mu-Yan Cai QiWu Hao Liu Wen-Long Guan Ai-Ping Zhou Yu-Jing Zhang Tian-Shu Liu Feng Bi Xiang-Lin Yuan Sheng-Xiang Rao Yan Xin Wei-Qi Sheng Hui-Mian Xu Guo-Xin Li Jia-Fu Ji Zhi-Wei Zhou Han Liang Yan-Qiao Zhang Jing Jin Lin Shen Jin Li Rui-Hua Xu 

机构地区：[1]Department of Medical Oncology,State Key Laboratory of Oncology in South China,Collaborative Innovation Center for Cancer Medicine,Sun Yat-sen University Cancer Center,Guangzhou,Guangdong 510060,P.R.China [2]Department of Gastrointestinal Oncology,Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education),Peking University Cancer Hospital and Institute,Beijing 100142,P.R.China [3]Department of Gastric Surgery,State Key Laboratory of Oncology in South China,Collaborative Innovation Center for Cancer Medicine,Sun Yat-sen University Cancer Center,Guangzhou,Guangdong 510060,P.R.China [4]Department of Radiology,Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education),Peking University Cancer Hospital and Institute,Beijing 100142,P.R.China [5]Department of Medical Oncology,The First Hospital of China Medical University,Shenyang,Liaoning 110001,P.R.China [6]Department of Medical Oncology,Zhejiang Cancer Hospital,Hangzhou,Zhejiang 310006,P.R.China [7]Department of Medical Oncology,Ruijin Hospital,Shanghai Jiaotong University School of Medicine,Shanghai 200025,P.R.China [8]Department of Surgical Oncology,The Fourth Affiliated Hospital of Harbin Medical University,Harbin,Heilongjiang 150001,P.R.China [9]Department of Medical Oncology,Fujian Cancer Hospital,Fuzhou,Fujian 350000,P.R.China [10]Department of Medical Oncology,Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology,Wuhan,Hubei 430030,P.R.China [11]Cancer Center of The First Hospital of Jilin University,Changchun,Jilin 130021,P.R.China [12]Department of Pathology,State Key Laboratory of Oncology in South China,Collaborative Innovation Center of Cancer Medicine,Sun Yat-sen University Cancer Center,Guangzhou,Guangdong 510060,P.R.China [13]Department of Endoscopy Center,Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education),Peking University Cancer Hospital and Institute,Beijing 100142,P.R.China [14]Department of General Surgery,Nanfang Hosp

出　　处：《Cancer Communications》2021年第8期747-795,共49页癌症通讯（英文）

摘　　要：There exist differences in the epidemiological characteristics,clinicopathological features,tumor biological characteristics,treatment patterns,and drug selections between gastric cancer patients from the Eastern and Western countries.The Chinese Society of Clinical Oncology(CSCO)has organized a panel of senior experts specializing in all sub-specialties of gastric cancer to compile a clinical guideline for the diagnosis and treatment of gastric cancer since 2016 and renews it annually.Taking into account regional differences,giving full consideration to the accessibility of diagnosis and treatment resources,these experts have conducted expert consensus judgment on relevant evidence and made various grades of recommendations for the clinical diagnosis and treatment of gastric cancer to reflect the value of cancer treatment and meeting health economic indexes in China.The 2021 CSCO Clinical Practice Guidelines for Gastric Cancer covers the diagnosis,treatment,follow-up,and screening of gastric cancer.Based on the 2020 version of the CSCO Chinese Gastric Cancer guidelines,this updated guideline integrates the results ofmajor clinical studies from China and overseas for the past year,focused on the inclusion of research data from the Chinese population for more personalized and clinically relevant recommendations.For the comprehensive treatment of non-metastatic gastric cancer,attentions were paid to neoadjuvant treatment.The value of perioperative chemotherapy is gradually becoming clearer and its recommendation level has been updated.For the comprehensive treatment of metastatic gastric cancer,recommendations for immunotherapy were included,and immune checkpoint inhibitors fromthird-line to the first-line of treatment for different patient groups with detailed notes are provided.

关 键 词：ADJUVANT chemotherapy Chinese Society of Clinical Oncology(CSCO) diagnosis gastric cancer IMMUNOTHERAPY NEOADJUVANT RADIOTHERAPY surgery targeted therapy 

分 类 号：R73[医药卫生—肿瘤]